Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000032

Options or other derivatives

  • Chief Business Officer acquired 115,000 shares (grant or award)
  • Chief Business Officer returned 115,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Boyle Scott N · Chief Business Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-07 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −115,000 0 D
2024-03-07 Grant or award : show line 2 in the form Stock Option (Right to Buy) +115,000 115,000 D
Loading xslF345X05/wk-form4_1709944127.xml…